Get the Stockscreener App
2.25
4.17%
0.09
After Hours:
2.25
Longeveron Inc stock is traded at $2.25, with a volume of 343.99K.
It is up +4.17% in the last 24 hours and up +21.62% over the past month.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
See More
Previous Close:
$2.16
Open:
$2.14
24h Volume:
343.99K
Relative Volume:
0.54
Market Cap:
$31.02M
Revenue:
$709.00K
Net Income/Loss:
$-21.41M
P/E Ratio:
-2.3684
EPS:
-0.95
Net Cash Flow:
$-19.70M
1W Performance:
+2.74%
1M Performance:
+21.62%
6M Performance:
+28.57%
1Y Performance:
-88.52%
1-Day Range:
$2.1227
$2.2605
1-Week Range:
$1.93
$2.2605
52-Week Range:
$0.7707
$23.90
Longeveron Inc Stock (LGVN) Company Profile
Name
Longeveron Inc
Sector
Industry
Phone
305-302-7158
Address
1951 NW 7TH AVENUE, MIAMI
Longeveron Inc Stock (LGVN) Latest News
Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - Marketscreener.com
Peeling Back The Layers: Exploring Longeveron Through Analyst Insights - Benzinga
Longeveron presents Alzheimer's therapy data at CTAD24 - Investing.com
Longeveron® Presents Lomecel-B™ Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - The Manila Times
Longeveron presents Alzheimer's therapy data at CTAD24 By Investing.com - Investing.com UK
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) - StockTitan
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - ForexTV.com
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - GlobeNewswire Inc.
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Why has Longeveron stock tripled in two days? - MSN
Euro FX (E6N18) Quote - The Globe and Mail
S&P 500 Index (INX) QuotePress Release - The Globe and Mail
Scholastic Corp (SCHL-Q) QuotePress Release - The Globe and Mail
LGVN’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
LGVNRLongeveron Inc. Latest Stock News & Market Updates - StockTitan
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) - ForexTV.com
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected - GlobeNewswire
Renaissance Technologies LLC Invests $236,000 in Longeveron Inc. (NASDAQ:LGVN) - Defense World
Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting - The Manila Times
Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - GlobeNewswire
Longeveron to Present at the UBS Virtual Organ Restoration and Cell Therapy Day - Marketscreener.com
Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day - The Manila Times
Longeveron to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - Marketscreener.com
Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - The Manila Times
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa - MSN
Longeveron to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa - The Manila Times
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa - StockTitan
Lamb Weston (LW) Scheduled to Post Quarterly Earnings on Tuesday - Defense World
Analysts review Longeveron Inc’s rating - Knox Daily
Lamb Weston (NYSE:LW) Price Target Raised to $75.00 - Defense World
Ratios Reveal: Breaking Down Longeveron Inc (LGVN)’s Financial Health - The Dwinnex
In the Green: Longboard Pharmaceuticals Inc (LBPH) Closes at 33.89, Up/Down 1.47 from Previous Day - The Dwinnex
Was there any good news for Longeveron Inc (LGVN) stock in the last session? - US Post News
Was Longboard Pharmaceuticals Inc (LBPH)’s session last reading good? - US Post News
Thrivent Financial for Lutherans Cuts Stock Holdings in Lamb Weston Holdings, Inc. (NYSE:LW) - Defense World
Lamb Weston Holdings, Inc. (NYSE:LW) Shares Acquired by Ensign Peak Advisors Inc - Defense World
American Century Companies Inc. Has $12.88 Million Holdings in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Police: 1 dead, 1 injured after shooting in Winton Hills - WLWT Cincinnati
Lamb Weston Holdings, Inc. (NYSE:LW) Shares Acquired by Elo Mutual Pension Insurance Co - Defense World
1 man killed, 1 injured in Winton Hills shooting - WKRC TV Cincinnati
Police: 37-year-old killed, man injured during shooting in Winton Hills - WCPO 9 Cincinnati
First Eagle Investment Management LLC Has $3.34 Million Stock Holdings in Luxfer Holdings PLC (NYSE:LXFR) - MarketBeat
Lamb Weston Holdings Inc [LW] moved down -0.24: Why It’s Important - The DBT News
Cincinnati police investigating after man shot, killed in Winton Hills - WLWT Cincinnati
Cedar Wealth Management LLC Takes Position in Lamb Weston Holdings, Inc. (NYSE:LW) - Defense World
First Eagle Investment Management LLC Has $11.97 Million Holdings in LSB Industries, Inc. (NYSE:LXU) - Defense World
Take off with Longeveron Inc (LGVN): Get ready for trading - SETE News
Virtu Financial LLC Makes New Investment in Lamb Weston Holdings, Inc. (NYSE:LW) - Defense World
Police identify man shot and killed in Winton Hills - FOX19
LGVN Shares Experience Surge in Value - Knox Daily
Investor’s Toolkit: Key Ratios for Assessing Longeveron Inc (LGVN)’s Performance - The Dwinnex
Longeveron Inc Stock (LGVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Longeveron Inc Stock (LGVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hare Joshua | Chief Scientific Officer |
Apr 11 '24 |
Buy |
2.35 |
42,553 |
100,000 |
633,280 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer |
Apr 11 '24 |
Buy |
2.35 |
10,638 |
24,999 |
19,616 |
| Soffer Rock | Director |
Apr 10 '24 |
Buy |
2.35 |
106,383 |
250,000 |
176,619 |
| Soffer Rock | Director |
Apr 11 '24 |
Buy |
2.35 |
31,915 |
75,000 |
208,534 |
| Ross Cathy | Director |
Jan 10 '24 |
Buy |
1.31 |
5,000 |
6,544 |
10,000 |
| Baluch Khoso | Director |
Dec 29 '23 |
Buy |
1.43 |
8,322 |
11,915 |
15,000 |
| Baluch Khoso | Director |
Dec 28 '23 |
Buy |
1.40 |
1,678 |
2,342 |
6,678 |
| PFEFFER JEFFREY | Director |
Dec 28 '23 |
Buy |
1.35 |
10,000 |
13,500 |
15,000 |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):